Image

An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK

An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to improve the early detection of lung cancer in adults who have smoked less than 100 tobacco cigarettes ("never-smokers") in the United Kingdom. The main questions it aims to answer are:

  • To describe characteristics such as demographics, co-morbidities and environmental exposures
  • To describe participant pathways including presentation mode and symptoms to understand if earlier diagnosis would be possible
  • To describe participant outcomes such as cancer stage, treatment and mortality
  • To quantitatively or qualitatively measure modifiable and non-modifiable factors that may be associated with LCINS including environmental measures, blood tests and genomic data.

Participants will currently have no change to their usual care.

Eligibility

Inclusion Criteria:

  • All adult participants from age of 18 who are diagnosed or treated with primary lung cancer through radiology or histology at any participating study site

Exclusion Criteria:

  • Participants who have ever smoked cigarettes or tobacco will be excluded; this is defined as:
    • More than 100 cigarettes or 75g tobacco in their lifetime
    • Those who have received a prescription for nicotine replacement therapy
  • For prospective participants, those who cannot consent will be excluded

Study details
    Lung Cancer

NCT06575439

University College London Hospitals

17 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.